13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 66 holding rows worth $481,099,000.
- Accession
- 0001387131-17-004132
- Filer
- CIK 1595851
- Filed
- 2017-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 66 entries on the cover page, a total value of $481,099,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $481,099,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CLOVIS ONCOLOGY INC | 189464100 | COM | 301,000 | $28,183,000 | thousands by filing date | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 350,000 | $27,013,000 | thousands by filing date | put |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 400,000 | $22,468,000 | thousands by filing date | put |
| Bristol-Myers Squibb Company | 110122108 | COM | 300,000 | $16,746,000 | thousands by filing date | call |
| AVEXIS INC | 05366U100 | COM | 190,000 | $15,610,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 300,000 | $15,522,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 425,000 | $15,177,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 150,000 | $13,110,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 200,000 | $12,818,000 | thousands by filing date | call |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 125,000 | $12,531,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 165,000 | $12,281,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 100,000 | $12,167,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 200,000 | $11,234,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,200,000 | $10,596,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 80,000 | $10,272,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 825,000 | $9,760,000 | thousands by filing date | |
| ENDO INTL PLC | G30401106 | SHS | 750,000 | $8,378,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 275,000 | $8,220,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 475,000 | $8,151,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 400,000 | $7,880,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 100,000 | $7,692,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 200,000 | $7,680,000 | thousands by filing date | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 275,000 | $7,670,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 300,000 | $7,389,000 | thousands by filing date | put |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 200,000 | $7,196,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 50,000 | $6,993,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 150,000 | $6,900,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 260,000 | $6,518,000 | thousands by filing date | |
| CURRENCYSHS BRIT POUND STER | 23129S106 | BRIT POUND STE | 50,900 | $6,455,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 150,000 | $6,374,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 500,000 | $6,210,000 | thousands by filing date | call |
| ENTELLUS MED INC | 29363K105 | COM | 375,000 | $6,210,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 500,000 | $5,860,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 350,000 | $5,789,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 45,000 | $5,475,000 | thousands by filing date | call |
| Gilead Sciences,Inc. | 375558103 | COM | 75,000 | $5,309,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 50,000 | $5,184,000 | thousands by filing date | call |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 250,000 | $5,140,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 350,000 | $4,900,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 750,000 | $4,853,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 175,000 | $4,851,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 300,000 | $4,221,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 196,287 | $4,163,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 175,000 | $4,058,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 550,000 | $4,043,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 50,000 | $3,982,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 675,000 | $3,753,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 650,000 | $3,744,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 200,000 | $3,666,000 | thousands by filing date | |
| K2M GROUP HLDGS INC | 48273J107 | COM | 150,000 | $3,654,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 500,000 | $3,650,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 70,000 | $3,547,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,100,000 | $3,003,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 250,000 | $2,863,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 200,000 | $2,794,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 90,000 | $2,735,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 200,000 | $2,484,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 250,000 | $2,473,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 89,295 | $2,357,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 150,000 | $2,265,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 300,000 | $2,208,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 35,000 | $2,091,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 85,000 | $1,593,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 100,000 | $1,450,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 50,000 | $957,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 125,000 | $580,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-17-004132 | this filing | 2017-08-14 | acceptance time not in the bulk data set |